Low-dose Interleukin-2 and Rapamycin on sjögren's Syndrome

NCT05605665 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Sjögren's Syndrome

Interventions

DRUG: low-dose interleukin-2
DRUG: rapamycin

Sponsor

Peking University People's Hospital